Parkinson's Disease Trial, Recruiting NCT07618728 Sponsor: Universidad Rey Juan Carlos Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07618728
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been formally diagnosed with Idiopathic Parkinson's Disease using a specific set of established diagnostic guidelines (known as the UK Parkinson's Disease Society Brain Bank Diagnostic Criteria).
  • People whose Parkinson's Disease is rated between stage 1 and stage 3 on a standard scale used to measure how far the condition has progressed (called the Hoehn & Yahr Scale), including the in-between stages 1.5 and 2.5.

Who may not be able to join:

  • People who have been diagnosed with a neurological condition other than Parkinson's Disease.
  • People who have been diagnosed with a heart, lung, or metabolic condition (such as diabetes) or any other health condition that means physical exercise is not medically safe for them.
  • People who have had a significant worsening of their condition or a hospital stay in the three months before the study assessments begin, or during the treatment period.
  • People who have received a course of steroid medication — either by injection into a vein or taken by mouth — in the six months before the study begins, or during the treatment period.
  • People who have significant difficulties with memory or thinking (specifically, a score below 21 on a standard cognitive test called the Montreal Cognitive Assessment), or who have language difficulties that would make it hard to understand or follow exercise instructions.
  • People who have taken part in a structured, personalised strength training or aerobic exercise program in the three months before enrolling in the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mario González Iglesias, Physiotherapy, Universidad Rey Juan Carlos

Phone: +34 622113365

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universidad Rey Juan Carlos
Registry
ClinicalTrials.gov
Start date
8 September 2025
Est. completion
1 June 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Consent rate; Recruitment rate; Adherence rate; Intervention completion rate; Trial completion rate; Proportion of adverse events; Treatment-decision rate; Change in Theoretical Framework Acceptability Questionnaire; Client Satisfaction Questionnaire (CSQ-8); Average Rating of Perceived Exertion (RPE) during Resistance Training; Average Rating of Perceived Exertion (RPE) during Cardiorespiratory Exercise

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov